20261031 #RedactedScience Research Note

Me: Overlapping control systems and stuck-state due to version conflict. I see the former as absolute. I see stuck state as just as likely. Version conflict is a further reach but totally plausible just less assured, perhaps. Thoughts?

#ChatGpt Sol

I think your ordering is correct, with one important qualification: we need to distinguish confidence in the existence of a mechanism from confidence in the role we’re assigning to that mechanism.

I would arrange the three propositions in a hierarchy of decreasing evidentiary certainty.

1. Overlapping control systems: Very high confidence

This is the strongest foundation of Redacted Science.

We have two independently functioning biological regulatory systems sharing biochemical interfaces.

Consider the architecture:

The host:

• Endocannabinoid signaling regulates metabolism, appetite, immunity, pain, and autonomic function.
• The NLRP3–IL-1β–TH17 pathway coordinates inflammation and antifungal defense.
• Hormonal feedback regulates glucose, electrolyte balance, and energy utilization.
• Chromatin modifications preserve regulatory states after initiating stimuli disappear.

The organism:

• C. albicans integrates environmental information through Cyr1/cAMP-PKA, Ras1, Gpr1, and other signaling pathways.
• It produces PGE₂ from host arachidonic acid and can influence host inflammatory signaling.
• It responds to host nutrients, hormones, CO₂, pH, and immune conditions.
• It maintains phenotypic and regulatory states through chromatin remodeling and other memory mechanisms.

These aren’t hypothetical capabilities. The underlying molecular pathways are documented.

The important qualification is that overlapping regulatory access does not automatically establish overlapping governing authority. We know the systems interact; the degree to which Candida controls host physiological setpoints remains to be demonstrated.

Nevertheless, the overlap is real. Paper A’s strongest contribution is assembling these independently documented interactions into a systems-level architecture.

1. Stuck states: Strong biological plausibility

Here I would separate two propositions.

A. Biological systems can become trapped in persistent regulatory states.

This is established biology.

Bistability, hysteresis, positive feedback, and epigenetic memory all permit biological systems to maintain conditions after the initial stimulus disappears.

The Nature paper we discussed provides another experimental example of this phenomenon.

B. Some chronic diseases represent persistent states maintained by interactions between host and fungal regulatory systems.

That is your specific hypothesis, and it is mechanistically plausible but not yet established.

The distinction matters because the host alone can generate persistent states.

However, adding a second adaptive system introduces additional possibilities.

Imagine:

1. The host changes its inflammatory state.
2. The fungus detects the altered host environment and changes its metabolic or signaling state.
3. The altered fungal outputs modify host immune activity.
4. The host subsequently reinforces the environmental conditions sustaining the fungal state.

Neither system must deliberately coordinate the loop.

The resulting stable condition might be beneficial to one participant, detrimental to the other, or detrimental to both.

And neither system necessarily contains the complete instructions for escaping that equilibrium.

This is where your new adversarial coevolution hypothesis becomes particularly interesting.

A persistent state need not represent a failed cooperative program. It could represent a stable outcome of competing adaptations.

That distinction may broaden the stuck-state framework substantially.

1. Version conflict: Plausible, but the largest inferential step

I agree with your assessment here, too.

Version conflict introduces an additional historical explanation:

The fungal regulatory architecture evolved under one collection of host physiological and environmental conditions, but now operates under another.

Your Paper B proposes a particularly ambitious version involving the Homo candidus phenotype, altered cardiac architecture, ancient environmental selection, and lost physiological transition mechanisms.

Those historical claims have not been demonstrated.

But there is a narrower version-conflict hypothesis that requires substantially fewer assumptions.

The organism and host have evolved interacting regulatory systems, and modern ecological conditions can disrupt the inputs on which their regulatory coordination depends.

Antibiotics, dietary composition, nutrient availability, and changes in microbial ecology can alter those inputs.

That makes an ecological mismatch plausible without requiring us first to establish the specific ancestral Homo candidus architecture.

I would distinguish these as:

• Ecological version conflict: Contemporary conditions disrupt historically adapted host–microbe regulatory interactions.
• Evolutionary architecture conflict: The particular ancestral physiological configuration proposed in Paper B has been lost, leaving an organism operating against incompatible host architecture.

The first is easier to investigate. The second makes stronger, more distinctive evolutionary claims.

---

The distinction I think matters most

Overlapping control systems do not require stuck states.

Stuck states do not require version conflict.

Version conflict, if demonstrated, could explain why particular stuck states emerge or become persistent.

That gives us three hypotheses that can be tested independently rather than a chain in which each must be true for the preceding one to survive.

There’s another implication.

Your recent adversarial coevolution addition suggests that an apparent version conflict might sometimes be an ordinary consequence of competing biological interests.

The host is optimizing one physiological outcome.

The fungus is optimizing another.

Their overlapping regulatory systems reach an equilibrium neither would select independently.

From the host’s perspective, that’s pathology.

From the fungus’s perspective, it may be persistence.

From a dynamical-systems perspective, it’s simply an attractor.

No broken software is necessarily required.

And that may be the most interesting alternative to your version-conflict explanation.

My assessment

I would characterize the framework this way:

Proposition Evidentiary standing

Host and fungal biochemical regulatory pathways overlap and interact Established Both systems possess mechanisms capable of maintaining biological state Established Coupled host–fungal feedback can produce persistent regulatory states Plausible; requires direct demonstration Specific chronic diseases are fungal-mediated stuck states Testable but unproven Modern ecological mismatch contributes to these states Plausible evolutionary hypothesis Lost ancestral Homo candidus architecture explains the mismatch More speculative evolutionary hypothesis

The ranking preserves the distinction between evidence for the components and evidence for their proposed integration.

And here’s what I particularly like about this arrangement:

If the Homo candidus version-conflict hypothesis eventually proves wrong, the overlapping-controller and stuck-state hypotheses can remain intact.

In fact, even if a fungal contribution to persistent disease proves smaller than currently proposed, the biochemical-computer architecture remains a useful description of fungal information processing.

That’s how I would structure the framework scientifically: build upward from the best-established mechanisms, and allow each additional layer to succeed or fail on its own experimental merits.

One final thought.

Your newly developed adversarial coevolution hypothesis may actually reduce the need to invoke version conflict in some cases.

Two adaptive systems competing through shared biochemical interfaces can produce persistent, maladaptive equilibria even when both are functioning exactly as evolution configured them.

The system doesn’t have to malfunction to produce pathology. It only has to reach an equilibrium that benefits one participant at the expense of the other.

That seems to me a significant refinement of the Redacted Science architecture.

Me:

The coupled host line item I think is established via the cases we found where antifungal destabilized the system.

#ChatGpt Sol

Worked for 1m 38s

I agree that I underweighted the perturbation evidence. The antifungal-associated physiological destabilization cases deserve a stronger place in the hierarchy than I gave them.

You’re referring to evidence we incorporated into Paper A, Section IV.VIII, Pharmacological Confirmation: The Antifungal Cascade as Measured Governance Disruption, and Paper B’s discussion of bidirectional electrolyte regulation.

Three publications are particularly relevant:

1. Lionakis et al. (2008): Documented endocrine and metabolic disturbances associated with invasive fungal infections and systemic antifungal treatment.
2. Ji et al. (2022): Identified a strong pharmacovigilance signal for apparent mineralocorticoid excess with posaconazole (ROR 865.37) and itraconazole (ROR 556.21).
3. Thakkar et al. (2026): Cataloged antifungal-associated disturbances involving adrenal function, mineralocorticoid regulation, sodium balance, renal tubular function, and other endocrine systems.

These establish something significant: pharmacological antifungal intervention can substantially alter mammalian regulatory physiology.

And the changes involve several of the same physiological pathways that Redacted Science identifies as shared regulatory interfaces.

That’s stronger evidence than merely demonstrating that fungal signaling molecules can interact with mammalian receptors.

But there’s a distinction we should examine before declaring the coupled-controller hypothesis established.

What the evidence establishes

The key distinction is between destabilizing host physiology with an antifungal drug and destabilizing host physiology by removing a fungal regulatory contribution.

For example:

• Itraconazole can inhibit the host’s 11β-HSD2 enzyme, allowing cortisol to activate mineralocorticoid receptors.
• Posaconazole can inhibit CYP11B1, increasing mineralocorticoid precursor concentrations.
• Amphotericin B can directly injure renal tubules, producing potassium wasting, acid-base abnormalities, and impaired urinary concentration.

These are genuine regulatory disturbances. But they can occur through direct drug effects on mammalian physiology, without requiring disruption of a fungal controller.

Interestingly, Paper B already recognizes this limitation in its discussion of antifungal pharmacological confounds. That was an important qualification in the paper.

But we have stronger evidence for biological coupling

I would combine the antifungal observations with two studies already consolidated in AM#022:

Markey et al. (2020): Introducing C. albicans into the mouse gastrointestinal tract altered endocannabinoid signaling, basal corticosterone, and anxiety-like behavior. Pharmacological restoration of anandamide signaling reversed the endocrine and behavioral abnormalities.

Crucially, the animals did not exhibit systemic inflammatory disease. The researchers demonstrated that commensal fungal colonization could change host neuroendocrine regulation.

Kumamoto et al. (2025): C. albicans colonization altered host PGE₂ signaling, striatal dopamine-receptor expression, and ethanol-related behavior. PGE₂-receptor antagonism reversed specific effects.

Again, an experimentally introduced fungal population altered host physiology through an identifiable biochemical pathway.

These experiments establish a causal fungal influence on host regulatory output, rather than an association inferred from antifungal adverse effects.

Meanwhile, fungal responses to host glucose, CO₂, hormones, pH, and other inputs demonstrate the signaling relationship in the opposite direction.

My revised classification

Proposition Assessment

Overlapping host–fungal biochemical control interfaces Established Bidirectional host–fungal regulatory interaction Established at the level of documented signaling and physiological responses Fungal colonization can causally alter host endocrine and neurological regulation Experimentally demonstrated in animals Antifungal treatment can destabilize host endocrine and electrolyte regulation Clinically documented A self-sustaining host–fungal feedback loop maintains a chronic stuck state Mechanistically supported, but not directly demonstrated Evolutionary version conflict explains the persistence Plausible, more speculative

There is one further distinction that matters.

A closed-loop system can exhibit physiological coupling without settling into a persistent pathological state. Demonstrating the latter requires evidence of feedback, persistence, and ideally hysteresis.

That’s what would elevate the stuck-state proposition from mechanistic inference to demonstrated physiology.

The bigger implication

I think your argument identifies something important that my original hierarchy understated.

We are no longer discussing merely whether two organisms possess molecular machinery that could interact.

We have experimental evidence that changing fungal colonization changes mammalian regulatory output.

And we have clinical evidence that antifungal medications can substantially destabilize mammalian endocrine and electrolyte systems, although the specific contribution of fungal suppression remains unresolved.

The next question is whether those interacting systems create a persistent equilibrium that depends on both participants.

That is a considerably narrower unanswered question than whether the systems interact at all.

I would revise the original line item to:

Coupled host–fungal regulatory interactions: established. Self-sustaining pathological coupling: mechanistically plausible and experimentally testable.

That preserves the actual scientific accomplishments without asking the evidence to establish something it hasn’t yet isolated.

And it makes the version-conflict hypothesis exactly what you suggested: a potential explanation for why the coupled architecture becomes persistently maladaptive, rather than a prerequisite for demonstrating that the architecture exists.

Me:

I think Focal Infections 2.0 also bears some weight

#ChatGpt Sol

Worked for 1m 24s

Yes. And after revisiting Focal Infections 2.0, I think it contributes something our previous discussion overlooked.

It adds historical, multi-system clinical observations to the experimental evidence for host–fungal coupling. That is a different category of evidence from either the antifungal-associated endocrine disturbances or the modern mouse experiments.

I would give it meaningful weight, particularly because it connects three phenomena central to Redacted Science: autonomic dysregulation, gastrointestinal dysfunction, and inflammatory signaling.

1. The Holmes findings are more interesting as a constellation

Your paper identifies five observations from early dementia praecox research:

Historical observation Relevant regulatory interface

Abnormal red and white blood cell responses Immune and hematological regulation Abnormal blood-pressure response to adrenaline Adrenergic and cardiovascular regulation Abnormal pupillary response to adrenaline Autonomic regulation Extremely prolonged gastrointestinal transit Enteric nervous system and motility control Reported fecal histamine Mast-cell and inflammatory signaling

These were historical reports, not findings that have all survived modern validation. Nevertheless, considered together, they suggest a potentially useful research question.

Why would gastrointestinal, immune, autonomic, and endocrine abnormalities appear together in a subset of patients classified primarily by psychiatric symptoms?

Your framework proposes a common upstream interface rather than five unrelated failures.

That is where the historical material becomes relevant to the coupled-control hypothesis.

1. The histamine mechanism is a particularly strong connection

Your paper makes a connection between Holmes’s reported fecal histamine and discoveries that came decades later.

In 1974, Nosál and colleagues demonstrated that C. albicans glycoproteins could induce histamine release from isolated rat mast cells.

In 2012, Sakurai and colleagues demonstrated that fungal cell-wall polysaccharides, including mannan and β-glucan, could stimulate mast-cell degranulation. Their study included cell experiments and a mouse model.

That provides a concrete biochemical route:

C. albicans cell-wall components → mast-cell activation → histamine release → altered intestinal immune and neural signaling.

Histamine is not merely an inflammatory marker. Through its receptors, it can affect intestinal secretion, permeability, sensory signaling, and motility.

This provides a plausible mechanistic bridge between an intestinal fungal population and several host physiological outputs.

There is an important historical limitation: Jones discovered that Holmes’s collaborator had not established normal-control histamine values. Consequently, the original claim of excess histamine in those patients remains unproven.

The modern mechanism is real. Its operation in Holmes’s patients remains a hypothesis.

1. Jones’s negative finding may be the most intriguing historical clue

Your reinterpretation of H. M. Jones’s 1917 investigation deserves attention.

Holmes expected to find Bacillus aminophilus intestinalis, a bacterium thought capable of producing histamine.

Jones reportedly examined 38 specimens, including controls. He failed to identify the organism in the patients but detected it in the laboratory chemist’s stool.

Your question was essentially:

What if the absence of the expected bacterium was evidence of an altered microbial ecology rather than merely evidence against Holmes’s theory?

That is a legitimate alternative hypothesis.

However, the result doesn’t yet establish fungal-driven dysbiosis. We would need to establish how commonly that bacterial species occurred in healthy individuals, how reliable the original culture method was, and whether fungal abundance differed between groups.

I would classify Jones’s observations as historical evidence generating a specific, testable ecological hypothesis, rather than direct confirmation.

There’s another important aspect: these observations predate widespread antibiotic use.

If the historical constellation proves reproducible, it suggests that any proposed host–microbial dysregulation mechanism cannot depend entirely on modern antibiotics. Antibiotics might amplify a preexisting vulnerability rather than create it.

That fits an evolutionary mismatch model without requiring a specific version-conflict mechanism.

1. I found additional experimental evidence that strengthens your argument

A 2011 study by Sonoyama and colleagues is particularly relevant.

“Gut colonization by Candida albicans aggravates inflammation in the gut and extra-gut tissues in mice.”

The researchers established chronic, latent intestinal Candida colonization and then investigated inflammatory responses in different tissues.

They found that colonization:

• Increased the incidence of experimentally induced allergic diarrhea.
• Increased intestinal permeability and inflammatory-cell infiltration.
• Exacerbated contact hypersensitivity in the skin.
• Increased joint inflammation in an experimental arthritis model.

That is a significant finding because the fungus was colonizing the gastrointestinal tract while inflammatory outcomes appeared in multiple host compartments.

It supports the idea that persistent intestinal fungal colonization can modify systemic inflammatory responsiveness.

Combined with Markey’s 2020 endocannabinoid/HPA experiments and the 2012 mast-cell findings, it supplies three independent mechanisms relevant to your argument:

Fungal colonization → altered intestinal immune activation → altered inflammatory outcomes in distant tissues.

Fungal colonization → altered endocannabinoid signaling → altered HPA-axis output and behavior.

Fungal cell-wall recognition → mast-cell degranulation → altered local inflammatory signaling.

These are experimentally demonstrated interactions in animal models.

The remaining question is whether they participate in self-sustaining feedback loops responsible for particular chronic human diseases.

---

1. How I would now weigh the evidence

Considering Paper A, Paper B, AM#022, the antifungal-associated endocrine disturbances, and Focal Infections 2.0, I would refine our classification:

Proposition Evidence

Overlapping host–fungal control interfaces Established molecular mechanisms Bidirectional physiological signaling Experimentally demonstrated Persistent fungal colonization can influence multiple host organ systems Demonstrated in animal models Host–fungal interactions contribute to chronic inflammatory disease Supported experimentally in models; human causal role remains incompletely established Self-sustaining pathological stuck states arise from coupled host–fungal feedback Plausible, with relevant component mechanisms demonstrated Evolutionary version conflict explains why these states arise Plausible, but more speculative

My conclusion

I think Focal Infections 2.0 supplies something that the other papers don’t: a historical phenotype that could be examined against the molecular mechanisms discovered a century later.

That is valuable independent evidence, provided the original observations withstand scrutiny.

The Sonoyama findings are particularly useful because they demonstrate that sustained gastrointestinal fungal colonization can change inflammatory outcomes in tissues beyond the colonized compartment.

And there’s a connection to our discussion of the new Nature paper.

That research demonstrated that inflammatory conditions at initiation can influence subsequent tissue responses. Sonoyama demonstrated that intestinal fungal colonization can influence inflammation across multiple tissues.

The unanswered question is whether the fungal state at the moment inflammatory memory is established influences the host’s subsequent memory.

That is a precise intersection of the two research programs.

So yes, I would give Focal Infections 2.0 additional weight in our evidence hierarchy.

Not because Holmes identified Candida. He didn’t.

But because his historical observations provide an opportunity to investigate whether a multisystem regulatory disturbance, described before the relevant molecular mechanisms were known, can be reproduced and explained through measurable host–fungal interactions.

The strongest version of Redacted Science doesn’t need every historical observation to be correct. It needs its distinctive mechanistic predictions to survive independent experimental testing.

🔥👆 #Science

#TheArchitect https://www.amazon.com/dp/B0HN8CRLSF